AAYUSH WELLNESS Q1 FY27 Results: Revenue Grows 46% to Rs 33 Crore, PAT Rises 23% to Rs 1 Crore

AAYUSH WELLNESS Q1 FY27: Revenue Rs 33 Cr (+46.3% YoY). PAT Rs 1 Cr (+22.55%). Gross profit Rs 0.77 Cr vs Rs 0.51 Cr (+51.57%). Consolidated. CMP Rs 24.08 on Aug 13.

Updated: 17 Aug 2026 • 3:03 pm

Posted by:

AAYUSH WELLNESS Q1 FY27 Results: Revenue Grows 46% to Rs 33 Crore, PAT Rises 23% to Rs 1 Crore

Quick Answer

AAYUSH WELLNESS Q1 FY27 results showed consolidated revenue growing 46.3% to Rs 33 crore from Rs 22 crore in Q1 FY26, with PAT rising 22.55% and gross profit improving 51.57% — strong performance in Ayurvedic and wellness products.

AAYUSH WELLNESS Q1 FY27 results showed the consolidated Ayurvedic and wellness products company posting 46.3% revenue growth to Rs 33 crore from Rs 22 crore in Q1 FY26. India's growing wellness market — driven by rising health awareness, premiumisation of natural health products, and expanding modern retail and e-commerce distribution — provided strong demand tailwinds.

The AAYUSH WELLNESS Q1 FY27 results showed gross profit improving 51.57% to Rs 0.77 crore from Rs 0.51 crore on 46% higher revenue, growing proportionately and confirming that the company is scaling without margin dilution in its wellness product manufacturing and distribution business.

Click Here – Get Free Investment Predictions

AAYUSH WELLNESS Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Crore)	Q1 FY26 (Rs Crore)	YoY Change
Revenue	33.00	22.00	+46.3%
Gross Profit	0.77	0.51	+51.57%
Net Profit / PAT	1.00	1.00	+22.55%

AAYUSH WELLNESS Q1 FY27 Performance Analysis

Use the Univest Screener to track AAYUSH WELLNESS live financials and Q1 FY27 results

AAYUSH WELLNESS Q1 FY27 results confirm the company is a beneficiary of India's secular wellness and Ayurvedic product growth trend, with 46% revenue growth significantly above the broader FMCG sector average.

Gross profit growing 52% on 46% revenue in Q1 FY27 confirms scale benefits — ingredient procurement at larger volumes and better manufacturing utilisation are improving per-unit economics without gross margin dilution.

PAT growing 23% to Rs 1 crore on 46% revenue growth — the PAT growth lagging revenue growth indicates operating costs are scaling alongside volumes, with operating leverage benefits to come as the company reaches larger revenue scale.

India's branded Ayurvedic and wellness market is growing at 12-15% annually, with premiumisation driving better realisations. AAYUSH WELLNESS's 46% growth significantly outpaces the category, indicating market share gains.

Key Business Factors in Q1 FY27

India Wellness Market Growth

46% revenue growth reflects the company's participation in India's fast-growing Ayurvedic and natural wellness product market.

Scale Without Margin Dilution

Gross profit growing proportionately confirms healthy unit economics as the business scales.

Premiumisation Trend

Rising consumer willingness to pay for premium Ayurvedic and immunity products benefits branded wellness companies.

Dividend Details

AAYUSH WELLNESS has not declared a dividend for Q1 FY27. Growth-phase reinvestment in product development and distribution is the priority.

FY27 Outlook

The FY27 outlook is positive with India's wellness product market momentum. Sustained 30%+ revenue growth would deliver accelerating PAT improvement through operating leverage as fixed costs are covered more efficiently.

Competition from large FMCG players entering the wellness space and raw herbal ingredient cost volatility are the primary risks to monitor.

AAYUSH WELLNESS Stock Performance

Download the Univest iOS App or Univest Android App to track AAYUSH WELLNESS share price live and stay updated on quarterly results.

AAYUSH WELLNESS shares traded at Rs 24.08 on August 13, 2026, up 2.88%, reflecting positive market reception of the strong Q1 FY27 growth.

Key Risks

FMCG Competition

Large companies with bigger marketing budgets entering Ayurvedic wellness create competitive pressure.

Ingredient Cost Volatility

Herbal and Ayurvedic raw materials face seasonal availability and crop-cycle price volatility.

Regulatory Compliance

AYUSH product regulations require ongoing quality and compliance investment as the regulatory framework evolves.

Conclusion

AAYUSH WELLNESS Q1 FY27 results show a compelling growth story with 46% revenue growth to Rs 33 crore and 23% PAT growth to Rs 1 crore — market share gains in India's structural wellness growth story.

Sustained execution at high growth rates is the key test. Consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).